Christopher Locher: Why Vaccine Innovation Matters More Than Ever
In this episode of the Vital Health Podcast, host Duane Schulthess speaks with Christopher Locher, Chief Executive Officer at Versatope Therapeutics, about the current landscape for vaccine manufacturers and innovators. Their conversation covers vaccine platform development, financing challenges for infectious disease companies, policy and regulatory uncertainty, the public health implications of changes to childhood immunization schedules, and the steps needed to rebuild trust in vaccination.
Key Topics:
Vaccine Platform Innovation: Nanoparticle technology, universal influenza vaccine…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.